Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the single-dose oral bioavailability of metformin
hydrochloride (HCI) liquid 500 mg/5 mL of Ranbaxy with GlucophageA® 1000 mg tablets of
Bristol-Myers, USA following administration of a 1000 mg dose in healthy, adult, male and
female volunteers under fed conditions